Combinatorial targeting of multiple myeloma by complementing T cell engaging antibody fragments
Geis et al. investigate the potential application of hemibodies, a pair of complementary antibody fragments that redirect T cells against cancer-defining antigen combinations, such as CD38 and SLAMF7, to target multiple myeloma. Their study provides evidence that hemibodies can be developed for effe...
Guardado en:
Autores principales: | Maria Geis, Boris Nowotny, Marc-Dominic Bohn, Dina Kouhestani, Hermann Einsele, Thomas Bumm, Gernot Stuhler |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3ee919498c4342e29413bd80927b94df |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
On-target restoration of a split T cell-engaging antibody for precision immunotherapy
por: Agnes Banaszek, et al.
Publicado: (2019) -
Complement dependent cytotoxicity activity of therapeutic antibody fragments is acquired by immunogenic glycan coupling
por: Courtois,Anthony, et al.
Publicado: (2012) -
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma
por: Elodie Duray, et al.
Publicado: (2021) -
F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement
por: AGUILAR,LORENA, et al.
Publicado: (2005) -
Does supportive supervisor complements the effect of ethical leadership on employee engagement?
por: Imtiaz Alam, et al.
Publicado: (2021)